A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-Cell epitope for the induction of a highly specific humoral immune response

被引：109

作者：

Dziadek, S

Hobel, A

Schmitt, E

Kunz, H

机构：

[1] Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55128 Mainz, Germany

[2] Johannes Gutenberg Univ Mainz, Inst Immunol, D-55101 Mainz, Germany

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2005年 / 44卷 / 46期

关键词：

antigens; antitumor agents; glycopeptides; synthetic vaccines; T-cell epitope;

D O I：

10.1002/anie.200501594

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

(Figure Presented) On target: With the fully synthetic vaccine 1 consisting of a tumor-associated sialyl-Tn glycopeptide antigen from the epithelial mucin MUC1 and a T-cell epitope from ovalbumin, a strong, highly specific immune response (IgG) directed against the glycopeptide antigen was induced in a mouse thereby realizing the most important requirement for the development of synthetic vaccines for the initiation of the body's own immune defense against tumors. © 2005 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

页码：7630 / 7635

页数：6

共 50 条

[1] Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response
Westerlind, Ulrika
Hobel, Alexandra
Gaidzik, Nikola
Schmitt, Edgar
Kunz, Horst
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (39) : 7551 - 7556
[2] Dendrimers of Vaccines Consisting of Tumor-Associated Glycopeptide Antigens and T Cell Epitope Peptides
Keil, Stefanie
Kaiser, Anton
Syed, Fauziya
Kunz, Horst
SYNTHESIS-STUTTGART, 2009, (08): : 1355 - 1369
[3] A Synthetic Vaccine Consisting of a Tumor-Associated Sialyl-TN-MUC1 Tandem-Repeat Glycopeptide and Tetanus Toxoid: Induction of a Strong and Highly Selective Immune Response
Kaiser, Anton
Gaidzik, Nikola
Westerlind, Ulrika
Kowalczyk, Danuta
Hobel, Alexandra
Schmitt, Edgar
Kunz, Horst
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (41) : 7551 - 7555
[4] Molecular Characterization of a Fully Human Chimeric T-Cell Antigen Receptor for Tumor-Associated Antigen EpCAM
Shirasu, Naoto
Yamada, Hiromi
Shibaguchi, Hirotomo
Kuroki, Motomu
Kuroki, Masahide
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
[5] Towards a fully synthetic carbohydrate-based anticancer vaccine: Synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated Tn antigen
Buskas, T
Ingale, S
Boons, GJ
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (37) : 5985 - 5988
[6] Induction of an epitope-specific humoral immune response by lipopeptide-hapten conjugates: Enhancement of the anti-melittin response by a synthetic T helper (T-h)-cell epitope
Hoffmann, P
Loleit, M
Mittenbuhler, K
Beck, W
Wiesmuller, KH
Jung, G
Bessler, WG
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1997, 17 (04): : 225 - 234
[7] INDUCTION OF ANTIBODIES TO A TUMOR-ASSOCIATED ANTIGEN BY IMMUNIZATION WITH A WHOLE MELANOMA CELL VACCINE
EUHUS, DM
GUPTA, RK
MORTON, DL
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 29 (04) : 247 - 254
[8] A Fully Synthetic Four-Component Antitumor Vaccine Consisting of a Mucin Glycopeptide Antigen Combined with Three Different T-Helper-Cell Epitopes
Palitzsch, Bjoern
Hartmann, Sebastian
Stergiou, Natascha
Glaffig, Markus
Schmitt, Edgar
Kunz, Horst
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2014, 53 (51) : 14245 - 14249
[9] T-cell response to p53 tumor-associated antigen in patients with colorectal carcinoma
Bueter, M
Gasser, M
Schramm, N
Lebedeva, T
Tocco, G
Gerstlauer, C
Grimm, M
Nichiporuk, E
Thalheimer, A
Thiede, A
Meyer, D
Benichou, G
Waaga-Gasser, AM
INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (02) : 431 - 438
[10] Towards the Development of Antitumor Vaccines: A Synthetic Conjugate of a Tumor-Associated MUC1 Glycopeptide Antigen and a Tetanus Toxin Epitope
Keil, Stefanie
Claus, Christine
Dippold, Wolfgang
Kunz, Horst
Angewandte Chemie (International Edition in English), 2001, 40 (02): : 366 - 369

← 1 2 3 4 5 →